CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis

NASDAQ:CCRN • US2274831047

8.61 USD
+0.25 (+2.99%)
At close: Feb 20, 2026
8.5 USD
-0.11 (-1.28%)
After Hours: 2/20/2026, 8:21:17 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, CCRN scores 5 out of 10 in our fundamental rating. CCRN was compared to 101 industry peers in the Health Care Providers & Services industry. CCRN has a great financial health rating, but its profitability evaluates not so good. CCRN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year CCRN was profitable.
  • In the past year CCRN had a positive cash flow from operations.
  • In multiple years CCRN reported negative net income over the last 5 years.
  • CCRN had a positive operating cash flow in 4 of the past 5 years.
CCRN Yearly Net Income VS EBIT VS OCF VS FCFCCRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • With a Return On Assets value of -2.91%, CCRN is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
  • CCRN's Return On Equity of -3.84% is in line compared to the rest of the industry. CCRN outperforms 46.53% of its industry peers.
  • CCRN has a Return On Invested Capital (0.98%) which is comparable to the rest of the industry.
  • CCRN had an Average Return On Invested Capital over the past 3 years of 15.05%. This is significantly above the industry average of 9.04%.
  • The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROIC 0.98%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
CCRN Yearly ROA, ROE, ROICCCRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • The Operating Margin of CCRN (0.56%) is worse than 60.40% of its industry peers.
  • In the last couple of years the Operating Margin of CCRN has declined.
  • CCRN's Gross Margin of 20.19% is in line compared to the rest of the industry. CCRN outperforms 44.55% of its industry peers.
  • In the last couple of years the Gross Margin of CCRN has declined.
Industry RankSector Rank
OM 0.56%
PM (TTM) N/A
GM 20.19%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
CCRN Yearly Profit, Operating, Gross MarginsCCRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCRN is still creating some value.
  • CCRN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CCRN has less shares outstanding
  • There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCRN Yearly Shares OutstandingCCRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CCRN Yearly Total Debt VS Total AssetsCCRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 4.44 indicates that CCRN is not in any danger for bankruptcy at the moment.
  • CCRN's Altman-Z score of 4.44 is fine compared to the rest of the industry. CCRN outperforms 79.21% of its industry peers.
  • There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.44
ROIC/WACC0.11
WACC8.72%
CCRN Yearly LT Debt VS Equity VS FCFCCRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
  • CCRN has a Current ratio of 3.45. This is amongst the best in the industry. CCRN outperforms 86.14% of its industry peers.
  • A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
  • CCRN's Quick ratio of 3.45 is amongst the best of the industry. CCRN outperforms 88.12% of its industry peers.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.45
CCRN Yearly Current Assets VS Current LiabilitesCCRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for CCRN have decreased strongly by -82.86% in the last year.
  • Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
  • CCRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.14%.
  • Measured over the past years, CCRN shows a quite strong growth in Revenue. The Revenue has been growing by 10.33% on average per year.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%

3.2 Future

  • Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -33.46% on average per year.
  • Based on estimates for the next years, CCRN will show a decrease in Revenue. The Revenue will decrease by -7.58% on average per year.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCRN Yearly Revenue VS EstimatesCCRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CCRN Yearly EPS VS EstimatesCCRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 71.75, CCRN can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as CCRN.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, CCRN is valued quite expensively.
  • The Price/Forward Earnings ratio is 71.34, which means the current valuation is very expensive for CCRN.
  • CCRN's Price/Forward Earnings ratio is in line with the industry average.
  • CCRN is valuated expensively when we compare the Price/Forward Earnings ratio to 28.02, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 71.75
Fwd PE 71.34
CCRN Price Earnings VS Forward Price EarningsCCRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • CCRN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CCRN is cheaper than 80.20% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, CCRN is valued cheaper than 91.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.18
EV/EBITDA 7.75
CCRN Per share dataCCRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CCRN's earnings are expected to decrease with -33.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.92
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CCRN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CROSS COUNTRY HEALTHCARE INC

NASDAQ:CCRN (2/20/2026, 8:21:17 PM)

After market: 8.5 -0.11 (-1.28%)

8.61

+0.25 (+2.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12
Earnings (Next)03-04
Inst Owners96.15%
Inst Owner Change-17.28%
Ins Owners6.14%
Ins Owner Change11.51%
Market Cap282.06M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts71.43
Price Target11.68 (35.66%)
Short Float %4.28%
Short Ratio1.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)-36.67%
EPS NQ rev (1m)-9.99%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
Industry RankSector Rank
PE 71.75
Fwd PE 71.34
P/S 0.25
P/FCF 6.18
P/OCF 5.2
P/B 0.69
P/tB 1.19
EV/EBITDA 7.75
EPS(TTM)0.12
EY1.39%
EPS(NY)0.12
Fwd EY1.4%
FCF(TTM)1.39
FCFY16.19%
OCF(TTM)1.66
OCFY19.23%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)2.92
Graham Number5.8
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROCE 1.39%
ROIC 0.98%
ROICexc 1.26%
ROICexgc 2.43%
OM 0.56%
PM (TTM) N/A
GM 20.19%
FCFM 4.05%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 49.56%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 229.81%
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.45
Altman-Z 4.44
F-Score5
WACC8.72%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year494.68%
EBIT Next 3Y80.04%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%

CROSS COUNTRY HEALTHCARE INC / CCRN FAQ

What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CCRN.


What is the valuation status for CCRN stock?

ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.


Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for CCRN stock?

The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.